Characteristics | n | Cases (%) | |
---|---|---|---|
GSE49997 | GSE9891 | ||
Histologic subtype | |||
 Serous | 435 | 171 (88.1%) | 264 (92.6%) |
 Non-serous | 44 | 23 (11.9%) | 21 (7.4%) |
FIGO stage | |||
 Stage 1 | 24 | 0 (0%) | 24 (8.4%) |
 Stage 2 | 27 | 9 (4.6%) | 18 (6.3%) |
 Stage 3 | 371 | 154 (79.4%) | 217 (76.1%) |
 Stage 4 | 53 | 31 (16.0%) | 22 (7.7%) |
 Unknown | 4 | 0 (0%) | 4 (1.4%) |
Grade | |||
 Grade 1 | 30 | 11 (5.7%) | 19 (6.7%) |
 Grade 2 | 136 | 39 (20.1%) | 97 (34.0%) |
 Grade 3 | 307 | 143 (73.7%) | 164 (57.5%) |
 Unknown | 6 | 1 (0.5%) | 5 (1.8%) |
Residual tumor | |||
 No | 221 | 137 (70.6%) | 84 (29.5%) |
 Yes | 221 | 57 (29.4%) | 164 (57.5%) |
 Unknown | 37 | 0 (0%) | 37 (13.0%) |